Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA reform act implementation summary document expected by end of February.

This article was originally published in The Tan Sheet

Executive Summary

FDA REFORM POINT-BY-POINT IMPLEMENTATION SUMMARY EXPECTED to be completed by the agency as early as February. The summary, which would come out of the Office of the Commissioner, is expected to describe the regulatory course of action the agency plans to take in response to the FDA Modernization & Accountability Act, signed into law Nov. 21. Unless otherwise specified in the act, the law takes effect mid-February. It is not known whether the agency's implementation document will be public or internal to FDA.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087966

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel